All News

joint.pain_.hand_.PIP_.jpg

Noninflammatory Pain Persists in RA Despite Treatment

d RheumNow

Almost one-third of patients with new-onset rheumatoid arthritis (RA) reported persistent unacceptable pain after 21 months of combination therapy, according to a study by Swedish researchers.A total of 29% of patients continued to have unacceptable pain.

Read Article
Military Air Force

U.S. Air Force - Basic Measures in Basic Training to Avoid COVID-19

d Jack Cush, MD

In the current issue of MMWR, the CDC reports that among military personnel starting basic training, the use of nonpharmaceutical interventions (NPI) may significantly reduce the risk of COVID-19 infection. NPIs advocated include screening measures, testing, administrative measures, quarantine, isolation, and source control, all as efforts to limit transmission COVID-19 in the community.

Read Article
Guselkumab improved axial symptoms, over 24 weeks in active PsA patients with radiographic sacroiliitis. Post-hoc analysis from Discover1&2 studies (Prof P Helliwell). #OP0054. #EULAR2020, >GF

ARD & RMD Open ARD_BMJ ( View Tweet)

Can fatigue in RA vary by bDMARD used? IL-6 inhibitor treatment associated with attaining a low fatigue state (RR 1.20 vs csDMARDs). Given IL-6 secretion with HPA axis activation leads to fatigue/poor sleep, maybe something in this? RABBIT database OP0020 #EULAR2020 @RheumNow https://t.co/wzFcqdUMMV
David Liew drdavidliew ( View Tweet)
17,500 people connected at moment at the largest e-Congress I could imagine #EULAR2020 #EULAR2020goesvirtual

Loreto Carmona 🖖 carmona_loreto ( View Tweet)

You've got at least two good reasons not to forget about cardiovascular risk in ankylosing spondylitis. Traditional and inflammatory: it's the double whammy. Mike Nurmohamed from @Reade_020 #EULAR2020 @RheumNow https://t.co/GLH7wzvrLN
David Liew drdavidliew ( View Tweet)
Use Of TNFi Before, During And The 1stY after Pregnancy Among Women With RA: Most of the women with RA were not treated with TNFi before or in pregnancy. Women w. RA that continue Rx with TNFi through pregnancy were using certilozumab and etanercept #EULAR2020 @RheumNow Abs0302 https://t.co/bWKrpx1hx7
Dr Philip Robinson philipcrobinson ( View Tweet)
Increased cardiovascular risk in: - AS patients (adj HR 4.6 vs non-rheum controls) - longer disease duration of inflammatory rheum disease (7% per year) in a Spanish national multicentre project (CARMA) w 5y follow-up Martin Martinez OP0002 #EULAR2020 @RheumNow https://t.co/BffbfPfkj0
David Liew drdavidliew ( View Tweet)
Consensus Statement: Use Of Jakinib Therapy In Immune Mediated Inflammatory Diseases: A consensus statement from @drpnash and others. Abstract AB0352. #EULAR2020 @RheumNow https://t.co/5uqwFoUglS https://t.co/fIZPWGHAPx

Links:

Dr Philip Robinson philipcrobinson ( View Tweet)

Certolizumab Pegol: A Safe And Efficient Treatment In Patients With Uveitis During Pregnancy: Conclusion: CZP seems to be effective and safe in female patients with uveitis during pregnancy and neonates. Abstract AB1055 #EULAR2020 @RheumNow https://t.co/MzeZKBawTg

Dr Philip Robinson philipcrobinson ( View Tweet)
Spinal Radiographic Progression in axSpA and the Impact Of Classification As non-radiographic Versus Radiographic Disease => Conclusion: Spinal structural damage is mainly restricted to patients with r-axSpA #OP0075 @XBaraliakos #EULAR2020 @RheumNow https://t.co/VYDwKfT44A https://t.co/G3kCN2ebzW

Links:

Dr Philip Robinson philipcrobinson ( View Tweet)
Population studies show #AS patients have a 36% increased risk of Cardiovascular mortality - most deaths being vascular disease relate #EULAR2020 https://t.co/H3CK81lEOb https://t.co/v6V5HlgRt1

Links:

Dr. John Cush RheumNow ( View Tweet)
46,311 #RA patients from the Swedish Rheumatology Quality Register were assessed for venous thromboembolism (VTE) risk. Increasing Dz activity increased the VTE risk #EULAR2020 OP0034 https://t.co/vEjKMMsT0U https://t.co/rzMMI9PlsV

Links:

Dr. John Cush RheumNow ( View Tweet)
Study of 21,525 RA patients in the Forward Databank finds 13.8% w/ lung disease (LD).RA-LD pts had more hospitalizations/deaths (HR 1.3) and 4 fold risk of resp-related events, not influenced by therapies. #EULAR2020 #OP0039 @RheumNow https://t.co/AgZcljDUDv https://t.co/Hl8Pc0YGnh

Links:

Dr. John Cush RheumNow ( View Tweet)
Case Controlled Study of 482 RA patients with ILD vs 741 RA w/o IL found an inverse relationship Between MTX exposure and ILD #EULAR2020 #OP0036 @RheumNow https://t.co/tfkBr0vyRP
Dr. John Cush RheumNow ( View Tweet)
Slightly crazy to be attending EULAR from my study. But crazy times #EULAR2020 @RheumNow https://t.co/X52Ep09GX4
Dr Philip Robinson philipcrobinson ( View Tweet)
I may not be allowed to go to Frankfurt for EULAR this year - but #EULAR2020 can come to me! Once again delighted to be tweeting for @RheumNow this meeting, and settling in for a big night in Australia of day 1 #EULAR2020goesvirtual (thanks @eular_org!) https://t.co/Mve8NY7EBn
David Liew drdavidliew ( View Tweet)
Waiting for godot....I mean #EULAR2020 https://t.co/mFP4Lwld4U
Dr. John Cush RheumNow ( View Tweet)
#EULAR2020 is off to a bad start https://t.co/Oc2ysedu4P
Dr. John Cush RheumNow ( View Tweet)
Abbvie has filed applications with the FDA and EMA for Rinvoq (upadacitinib) as a potential Treatment of Adults with Active Psoriatic Arthritis. https://t.co/8mnOE4M2y1

Links:

Dr. John Cush RheumNow ( View Tweet)

How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×